Optishine Vitreo Eye Drops

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Beli sekarang

Download Risalah maklumat (PIL)
29-01-2017
Download Ciri produk (SPC)
29-01-2017

Bahan aktif:

Potassium Iodide; Sodium Iodide

Boleh didapati daripada:

Y.S.P. INDUSTRIES (M) SDN. BHD.

INN (Nama Antarabangsa):

Potassium Iodide; Sodium Iodide

Unit dalam pakej:

10mlx12units Units; 10mlx10units Units; 10mlx1units Units; 10mlx20units Units; 10mlx24units Units

Dikeluarkan oleh:

Y.S.P. INDUSTRIES (M) SDN. BHD.

Risalah maklumat

                                _CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
OPTISHINE VITREO EYE DROPS
Potassium Iodide (0.3%), Sodium Iodide (0.3%), Chlorhexidine Acetate
(0.01%)
1
WHAT IS IN THIS LEAFLET
1.
What
OPTISHINE
VITREO
EYE
DROPS is used for
2.
How
OPTISHINE
VITREO
EYE
DROPS works
3.
Before
you
use
OPTISHINE
VITREO EYE DROPS
4.
How to use OPTISHINE VITREO
EYE DROPS
5.
While you are using it
6.
Side effects
7.
Storage
and
Disposal
of
OPTISHINE VITREO EYE DROPS
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT
OPTISHINE
VITREO
EYE
DROPS IS USED FOR
It is used to treat opacity and bleeding
through the vitreous body of any cause
(age,
myopia,
hypertonia,
diabetes,
periphlebitis), clouding of the lens as a
first sign of cataracta senilis,
HOW
OPTISHINE
VITREO
EYE
DROPS WORKS
Iodide
(Potassium
iodide
and
sodium
iodide) is an ingredient which has been
known to be able to stimulate the tissues
of
the
eye
ball
by
increasing
its
metabolism
rate.
As
our
eyes
have
a
natural
way
of
clearing
up
unwanted
substances out from the eye through the
process of absorption by these tissues
that surrounds the vitreous humor back
into
the
bloodstream,
the
increased
metabolism rate can expedite this eye
clearing process.
BEFORE YOU USE OPTISHINE VITREO
EYE DROPS
-
_When you must not use it_
_ _
If you experience eye pain, changes in
vision, continued redness or irritation
of the eye, or if symptoms worsen or
persists,
discontinue
use
of
OPTISHINE VITREO EYE DROPS.
_ _
-
_Before you start to use it _
Tell your doctor if you are taking any
other medicines or you have any other
health problems.
-
_Taking other medicines _
Tell your doctor if you are taking any
other
medicines,
including
any
that
you buy without a prescription from a
pharmacy, supermarket or health food
shop.
HOW TO USE OPTISHINE VITREO
EYE DROPS
-
_How much to use _
Follow all directions given to you by
your doctor and pharmacist carefully.
They may differ from the information
contained in this leaflet. If you do not
understand
the
instruction
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                OPTISHINE VITREO EYE DROPS
Each ml contains:
_Active Ingredient(s):_
Potassium Iodide
……..........................................................................................……
3.0mg
Sodium Iodide
………...................................................................................................
3.0mg
_Preservative:_
Chlorhexidine Acetate
..................................................................................................
0.1mg
PHARMACOLOGY (SUMMARY OF PHARMACODYNAMIC AND PHARMACOKINETIC):
PHARMACODYNAMIC:
Systemic as well as topical application of iodides can activate the
metabolism and
occasionally counteract cloudiness of the vitreous body.
The effect of iodine on early senile cataract has not yet been
established. Occasionally it is
possible to slow down the progression of cloudiness and the
degradation of visual acuity.
PHARMACOKINETIC:
a) local administration into the eye:
Potassium iodide diffuses rapidly into the vitreous humour of the
isolated rabbit’s eye.
Within 60 minutes 0.25 μmoles of potassium iodide accumulate in 1 ml
of aqueous
humour. 6.4% of the iodide present in the treated eye was found in the
lens and 3.7%
in the vitreous body.
b) systemic administration:
The degree of systemic resorption after local administration into the
eye has not been
investigated.
INDICATION(S):
Therapeutic uses:
Opacity and bleeding through the vitreous body of any cause (age,
myopia, hypertonia,
diabetes, periphlebitis), clouding of the lens as a first sign of
cataracta senilis.
DOSAGE AND ADMINISTRATION(S):
Apply 1 drop into the conjunctival sac 1-3 times a day.
MODE OF ADMINISTRATION(S):
Ophthalmic.
CONTRAINDICATION(S):
People allergic to any ingredient in this product should not use it.
This product is contraindicated with functional disturbances of the
thyroid or a bland
nodular struma.
WARNING AND PRECAUTIONS(S):
Carriers of contact lenses should apply the product during the time
when the lenses are not
worn. Wait at least 30 minutes after the administration of the
preparat
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bahasa Melayu 29-01-2017

Cari amaran yang berkaitan dengan produk ini